COMP <GO>
HURA vs BGM // EV/EBITDA & P/E VALUATION
TuHURA Biosciences Inc. (NASDAQ) VS. BGM Group Ltd. (Class A) (NASDAQ) • 15-METRIC TALLY: HURA 1
— BGM 3
■ METRIC PARITY
LAST: $1.93 (-6.31%) • MKT CAP: $131.3M
valuation
—
LAST: $9.54 (0.00%) • MKT CAP: $127.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HURA VS. BGM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HURA | BGM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 16.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.10% | -3.09% | -18.01 | BGM | /fcf-yield <GO> |
| Operating Margin | — | -33.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -52.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 51.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | BGM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 56.6 | -9.16 | BGM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $131.3M | $127.4M | $3.9M | HURA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HURA REV | BGM REV | HURA GROSS % | BGM GROSS % | HURA FCF | BGM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $37.9M | — | 16.6% | -$27.7M | -$3.9M |
| FY 2024 | $0 | $25.1M | — | 16.4% | -$14.8M | $304.1K |
| FY 2023 | $0 | $46.5M | — | — | -$12.0M | $312.2K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HURA // BETA —
BGM // BETA —